CJC-1295 is a modified GHRH analog research peptide engineered for extended half-life, used in laboratory studies of sustained growth hormone axis stimulation and IGF-1 signaling in preclinical models.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone modified with amino acid substitutions that resist enzymatic cleavage, substantially extending its active life compared to native GHRH. Laboratories use it to model sustained GHRH receptor activation and to examine prolonged growth hormone and IGF-1 elevation in controlled research settings.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution with bacteriostatic water and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
CJC-1295 is a modified GHRH analog research peptide engineered for extended half-life, used in laboratory studies of sustained growth hormone axis stimulation and IGF-1 signaling in preclinical models. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
Every batch of CJC-1295 is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.
